MLKL and renal fibrosis: Regarding the effect of Dapa and RIP inhibitors on necroptosis, sterile inflammation, and fibrosis, we suggest that Dapa alleviates renal fibrosis in this model of UUO may be associated with suppression of PIR1-PRI3-MLKL-mediated necroinflammation.